CuraTeQ Biologics (a wholly owned subsidiary of Aurobindo Pharma Ltd.) is a biopharmaceutical company based out of Hyderabad, India. Our vision is to improve the wellbeing of patients suffering from debilitating illnesses by providing them access to high quality and cost-effective biosimilars. 

CuraTeQ has a development pipeline of 14 biosimilars, of which, three products have been filed with EMA, one product has been filed with MHRA, and four more products are in global phase 3 clinical trials.

Our Mission:
● Deliver exceptional value to stakeholders and better health outcomes to patients by becoming a leading global biosimilars developer by 2030.
● Build deep capabilities in development and manufacturing to deliver quality and cost-effective biosimilars for patients across the globe.
● Create a sustainable and broad portfolio of biosimilars with a focus on oncology and immunology therapies.

CuraTeQ Biologics

Similar companies